Esther de Hoop

Esther de Hoop is an active researcher in the Hematology department at Erasmus University Medical Center, specializing in oncology and pharmacology research with particular expertise in breast cancer treatment, pharmacokinetics, and drug interactions. Her research focuses on optimizing cancer therapies through personalized medicine approaches and improving patient outcomes through better understanding of drug behavior and treatment responses.

Dr. de Hoop's research interests primarily center around pharmacokinetics, breast cancer treatment optimization, endocrine therapy, and drug-drug interactions. She has made significant contributions to understanding how to individualize chemotherapy dosing, particularly with fluoropyrimidines and endocrine therapies, and has investigated the impact of newer medications like semaglutide on cancer drug bioavailability. Her work bridges clinical pharmacology and practical cancer treatment, aiming to improve both efficacy and safety of therapeutic regimens.

Her recent publications demonstrate a strong focus on

• Personalized dosing strategies based on pharmacokinetic monitoring
• Drug-drug interactions in cancer patients
• Optimization of endocrine therapy for breast cancer
• Management of treatment-related complications like thromboembolism
• Patient-centered approaches to decision-making in clinical trials

Dr. de Hoop collaborates extensively with other researchers at Erasmus MC, particularly in studies involving pharmacogenomics, treatment response prediction, and real-world outcomes of cancer therapies. Her work has practical implications for clinical practice, helping to refine treatment protocols and improve patient safety.